Go All-In On Actavi...
Health Care: Drugs
NABI Biopharmaceuticals Inc. (NABI: NASDAQ)
$10.80 0.00 | 0.00%
11/12/12 - 12:15 AM ET
0.00 / 178.80K
Vol / Avg. Vol:10.80 / 10.80
Open / Prev. Close:10.80 - 10.80
Today's Range:1.77 - 12.18
52 Wk Range:0.00%
Performance YTD:TheStreet Rating:
Portfolios with NABI
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserPRossmango - Speculative Lo...
- Contributor10 Biotech Stocks Expected ...
- ContributorBarron's Activist Stocks 5-...
- ContributorBarron's Activist Stocks 4-...
- ContributorBarron's Activist Stocks 4-...
- Userwlpncp Portfolio 1
- ContributorCharts of the Week - 1-27-2009
- ContributorBarron's Insider Purchases ...
Latest NABI Headlines from TheStreet
- Nabi Biopharmaceuticals Announces Nabi Stockholder Meeting Results And The Approval Of The Business Combination Transaction By Biota Stockholders 10.23.12 | 05:10 pm
- Nabi Biopharmaceuticals Announces Exchange Ratio For Proposed Business Combination Transaction With Biota Holdings Limited 10.19.12 | 07:10 am
- Nabi Biopharmaceuticals Announces Results Of NicVAX(R) Phase II Study In Combination With Varenicline 10.17.12 | 07:10 am
- Nabi Biopharmaceuticals Sets Record Date For Cash Dividend 10.16.12 | 04:10 pm
- Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceutical Stockholders Support Amended Transaction With Biota Holdings Limited At October 22nd Reconvened Special Meeting 10.16.12 | 08:10 am
- Nabi Biopharmaceuticals Announces Adjournment Of Special Meeting Of Stockholders Until October 22, 2012 09.24.12 | 03:09 pm
- Nabi Biopharmaceuticals And Biota Holdings Limited Amend Terms Of Business Combination; Mangrove Partners Agrees To Support The Amended Transaction 09.17.12 | 05:09 pm
- Biota In Advanced Discussions With Russell H. Plumb To Assume Role Of President And CEO Of Biota Pharmaceuticals, Inc. 09.06.12 | 04:09 pm
- Nabi Sends Letter To Stockholders Responding To Mangrove's Statements And Calls On Stockholders To Vote Their White Proxy Card Today 08.23.12 | 06:08 am
- Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results 08.09.12 | 04:08 pm
Press Releases for NABI
- Mangrove Partners Agrees To Support Amended Transaction Between Nabi Biopharmaceuticals And Biota Holdings - PR Newswire 09.19.12 | 09:09 pm
- ISS And Glass Lewis Both Recommend That Stockholders Vote Against The Nabi/Biota Merger - PR Newswire 09.12.12 | 08:09 pm
- Mangrove Partners Sends Letter To Stockholders Of Nabi Biopharmaceuticals - PR Newswire 08.16.12 | 09:08 am
Partner Headlines for NABI
- Mangrove Partners Sends Letter to Holders of Nabi Biopharma; Urges Vote Against Merger - Benzinga 08.16.12 | 09:08 am
- Company News for July 19, 2011 - Corporate Summary - Zacks 07.19.11 | 10:07 am
- Seth Hamot: Look for Bad Business Models, Too Much Leverage and Selfish Management - Seeking Alpha 07.07.10 | 08:07 am
- Dan Loeb's Hedge Fund Third Point Starts Multiple New Positions, Exits Citigroup - Seeking Alpha 05.24.10 | 05:05 pm
- Nabi Vaccine Program Advances - Analyst Blog - Zacks 03.19.10 | 04:03 pm
